Hui-Hua Chang

Associate Professor

  • 340 Citations
  • 10 h-Index
20092019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2011 PhD, Institute of Biopharmaceutical Sciences, National Cheng Kung University

Experience

  • 2018/02 ~ present Associate Professor, School of Pharmacy, National Cheng Kung University
  • 2018/02 ~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
  • 2014/08 ~ 2018/02 Assistant Professor, School of Pharmacy, National Cheng Kung University
  • 2013/02 ~ 2018/02 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
  • 2011 ~ 2013 Postdoctoral Fellow, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF)

Research Interests

  • Pharmacogenomics
  • Human Microbiome
  • Personalized Medicine
  • Bioinformatics
  • Clinical pharmacy

Fingerprint Dive into the research topics where Hui-Hua Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Major Depressive Disorder Medicine & Life Sciences
Bipolar Disorder Medicine & Life Sciences
Antidepressive Agents Medicine & Life Sciences
Valproic Acid Medicine & Life Sciences
C-Reactive Protein Medicine & Life Sciences
Depression Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2018

Research Output 2009 2019

  • 340 Citations
  • 10 h-Index
  • 26 Article
  • 2 Letter
  • 1 Conference contribution
Open Access
ovaries
Polycystic Ovary Syndrome
Metformin
polymorphism
Polymorphism

Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors

Hsueh, Y. S., Chang, H-H., Shan, Y-S., Sun, H-F., Fletcher, J. A., Li, C. F. & Chen, L. T., 2019 Jan 1, In : Oncogene.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Stromal Cells
Chromatin Immunoprecipitation
Valproic Acid
Carcinogenesis
Major Depressive Disorder
Body Mass Index
Homeostasis
Fingers
Insulin Resistance
2 Citations (Scopus)
Valproic Acid
Bipolar Disorder
Therapeutics
Depression
Body Weight
1 Citation (Scopus)

A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate

Chen, P-S., Chang, H-H., Huang, C-C., Lee, C. C., Lee, S. Y., Chen, S. L., Huang, S. Y., Yang, Y-K. & Lu, R-B., 2017 Mar 1, In : Pharmacogenomics Journal. 17, 2, p. 155-161 7 p.

Research output: Contribution to journalArticle

Guanine Nucleotides
Protein Subunits
Valproic Acid
Longitudinal Studies
Carrier Proteins

Thesis

FGF21 and LEPR polymorphisms predict valproate treatment outcome in patients with bipolar II disorder

Author: 詠文, 鄭., 2018 Apr 30

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis

Plasma oxytocin level and OXTR predict antidepressant treatment outcome in patients with major depressive disorder

Author: 宜靖, 彭., 2016 Aug 18

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis

Predicting factors for valproate treatment outcome among bipolar II patients – focused on GNB3 and CRP level

Author: 俊頡, 李., 2015 Jul 6

Supervisor: Chang, H. (Supervisor)

Student thesis: Master's Thesis